Document is current
Any future updates will be listed below
-
Authors
Raffaelli, Bianca
Terhart, Maria
Mecklenburg, Jasper
Neeb, Lars
Overeem, Lucas Hendrik
Siebert, Anke
Steinicke, Maureen
Reuter, Uwe
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 23 February 2022
Accepted: 21 March 2022
First Online: 30 March 2022
Declarations
:
: The study was approved by the Charité Ethical Committee (EA1/274/19). Written informed consent was obtained from all participants.
: Not applicable.
: BR reports research grants from Novartis, and personal fees from Allergan, Hormosan, Lilly, Novartis, and Teva. MT reports personal fees from TEVA. JM reports personal fees from Novartis. AS reports personal fees from TEVA and Novartis. LN has contributed to the advisory boards of Hormosan, Lilly, Novartis, and Teva, and received speaking fees from Allergan, Bial, Hormosan, Lilly, Novartis, and Teva; LN received research funding from Deutsche Zentrum für Luft- und Raumfahrt. UR received honoraria for consulting and lectures from Amgen, Allergan, Abbvie, Eli Lilly, Lundbeck, Novartis, electroCore, Medscape, StreaMedUp, and Teva. UR received research funding from the German Federal Ministry of Education and Research and Novartis. The other authors have nothing to disclose.
